Wellington Management Group LLP Sells 862,015 Shares of Acadia Healthcare Company, Inc. $ACHC

Key Points

• Wellington Management Group LLP reduced its stake in Acadia Healthcare by 7.3%, selling 862,015 shares, and now holds 10,872,728 shares or approximately 11.80% of the company.
• Acadia Healthcare reported earnings of $0.83 per share in the last quarter, exceeding analyst expectations, with a revenue increase of 9.2% year-over-year.
• Research firms have varied ratings on Acadia Healthcare, with Barclays lowering its target price from $28.00 to $20.00 while other analysts maintain a consensus rating of "Moderate Buy" with a target price of $40.77.

Wellington Management Group LLP decreased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,872,728 shares of the company's stock after selling 862,015 shares during the period. Wellington Management Group LLP owned about 11.80% of Acadia Healthcare worth $329,661,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after purchasing an additional 1,234 shares during the last quarter. State of Wyoming bought a new position in Acadia Healthcare in the 4th quarter valued at approximately $56,000. Covestor Ltd increased its position in Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after acquiring an additional 812 shares during the period. Finally, Aquatic Capital Management LLC acquired a new position in Acadia Healthcare in the 4th quarter valued at approximately $97,000.

Acadia Healthcare Stock Down 1.8%

NASDAQ:ACHC traded down $0.4150 during trading hours on Monday, reaching $22.0250. The company had a trading volume of 349,269 shares, compared to its average volume of 2,192,186. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 14.58, a P/E/G ratio of 4.42 and a beta of 0.88. The business's 50-day simple moving average is $21.92 and its two-hundred day simple moving average is $26.01. Acadia Healthcare Company, Inc. has a twelve month low of $17.13 and a twelve month high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business's quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ACHC. UBS Group decreased their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Raymond James Financial restated an "outperform" rating and issued a $26.00 price target (down from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Mizuho decreased their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research report on Wednesday, August 13th. KeyCorp decreased their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Finally, Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Nine investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.